Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up

scientific article published on 01 September 2007

Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1365-2036.2007.03415.X
P698PubMed publication ID17697208

P50authorMarco DapernoQ53242942
Gianmichele MeucciQ57131104
Angelo ViscidoQ57692716
P2093author name stringGasbarrini A
Orlando A
Riegler G
Annese V
Cappello M
Armuzzi A
Biancone L
Prantera C
Sostegni R
Kohn A
Peralta S
Marrollo M
P433issue5
P921main subjectulcerative colitisQ1477
P304page(s)747-756
P577publication date2007-09-01
P1433published inAlimentary Pharmacology & TherapeuticsQ4726656
P1476titleInfliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up
P478volume26

Reverse relations

cites work (P2860)
Q37983558A systematic review and meta-analysis of the effects of infliximab on the rate of colectomy and post-operative complications in patients with inflammatory bowel disease
Q33564081Anti-TNF alpha in the treatment of ulcerative colitis: a valid approach for organ-sparing or an expensive option to delay surgery?
Q84145760Anti-TNF-alpha therapies do not increase early postoperative complications in patients with inflammatory bowel disease. An Italian single-center experience
Q38259532Biological therapy for ulcerative colitis: an update
Q53122367Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial.
Q36541160Clinical outcomes and predictive factors in oral corticosteroid-refractory active ulcerative colitis
Q37245232Controversies in ulcerative colitis: a survey comparing decision making of experts versus community gastroenterologists
Q37414620Cost-Effectiveness of Infliximab for the Treatment of Acute Exacerbations of Ulcerative Colitis in the Netherlands
Q34883210Current and emerging drugs for the treatment of inflammatory bowel disease
Q33586890Fulminant legionellosis in two patients treated with infliximab for Crohn's disease: case series and literature review
Q26827444Hepatitis B and C virus reactivation in immunosuppressed patients with inflammatory bowel disease
Q37825016Hepatitis B virus infection and immunosuppressive therapy in patients with inflammatory bowel disease
Q38056807Infliximab versus cyclosporine as rescue therapy in acute severe steroid-refractory ulcerative colitis: a systematic review and meta-analysis
Q33574857Long-term efficacy of infliximab for refractory ulcerative colitis: results from a single center experience
Q36167512MANAGEMENT OF ACUTE SEVERE ULCERATIVE COLITIS: A CLINICAL UPDATE.
Q35100746Management of acute colitis and toxic megacolon
Q26777729Medical Therapy of Active Ulcerative Colitis
Q53339638Modulation of Th1/Th2 balance by infliximab rescues postoperative occurrence of small-intestinal inflammation associated with ulcerative colitis.
Q26866940Optimization of the treatment with immunosuppressants and biologics in inflammatory bowel disease
Q38240881Predictors of response to anti-tumor necrosis factor therapy in ulcerative colitis
Q91789026Real World Effectiveness of Golimumab Therapy in Ulcerative Colitis Regardless of Prior TNF Exposure
Q42730491Recent advances in the management of distal ulcerative colitis
Q26852581Recommendations for the treatment of ulcerative colitis with infliximab: a gastroenterology expert group consensus
Q26823221Review article: applying pharmacokinetics to optimise dosing of anti-TNF biologics in acute severe ulcerative colitis
Q30239077Review article: dose optimisation of infliximab for acute severe ulcerative colitis
Q37189011Steroid-refractory severe ulcerative colitis: what are the available treatment options?
Q38726448Systematic Review and Meta-Analysis: Infliximab or Cyclosporine as Rescue Therapy in Patients With Severe Ulcerative Colitis Refractory to Steroids
Q61821109Systematic Review and Meta-analysis: Optimal Salvage Therapy in Acute Severe Ulcerative Colitis
Q37141131The use of infliximab for treatment of hospitalized patients with acute severe ulcerative colitis
Q28073443Update on medical and surgical options for patients with acute severe ulcerative colitis: What is new?
Q35046196Usefulness of the cytomegalovirus antigenemia assay in patients with ulcerative colitis

Search more.